Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic asthma.

× No keyword cloud information.

42 in total

Review 1. Efficacy and safety of inhaled corticosteroids. New developments.

Authors: P J Barnes; S Pedersen; W W Busse
Journal: Am J Respir Crit Care Med Date: 1998-03 Impact factor: 21.405

2. A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma.

Authors: D I Bernstein; R Cohen; E Ginchansky; A J Pedinoff; D G Tinkelman; J A Winder
Journal: J Allergy Clin Immunol Date: 1998-04 Impact factor: 10.793

3. Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma.

Authors: E Bronsky; P Korenblat; A G Harris; R Chen
Journal: Ann Allergy Asthma Immunol Date: 1998-04 Impact factor: 6.347

4. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.

Authors: W W Busse; P Chervinsky; J Condemi; W R Lumry; T L Petty; S Rennard; R G Townley
Journal: J Allergy Clin Immunol Date: 1998-04 Impact factor: 10.793

5. A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma.

Authors: J W Ramsdell; L Fish; D Graft; N Higgins; M Kavuru; W Pleskow; D Banerji
Journal: Ann Allergy Asthma Immunol Date: 1998-05 Impact factor: 6.347

6. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.

Authors: R A Nathan; J L Pinnas; H J Schwartz; J Grossman; S W Yancey; A H Emmett; K A Rickard
Journal: Ann Allergy Asthma Immunol Date: 1999-06 Impact factor: 6.347

7. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma.

Authors: E R McFadden; T B Casale; T B Edwards; J P Kemp; W J Metzger; H S Nelson; W W Storms; M J Neidl
Journal: J Allergy Clin Immunol Date: 1999-07 Impact factor: 10.793

8. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

Authors: J P Kemp; D A Cook; G A Incaudo; J Corren; C Kalberg; A Emmett; F M Cox; K Rickard
Journal: J Allergy Clin Immunol Date: 1998-02 Impact factor: 10.793

Chronic asthma.

Review 1. Efficacy and safety of inhaled corticosteroids. New developments.

2. A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma.

3. Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma.

4. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.

5. A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma.

6. A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.

7. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma.

8. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

9. A 15-year follow-up study of ventilatory function in adults with asthma.

10. Effect of long-term salmeterol treatment on exercise-induced asthma.

1. [Modifications in asthma patients' knowledge of the use of inhalers].

2. Informal medicine: ethical analysis.